Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)
Clinical trial NCT05360966 · COMPLETED
Trial details
- NCT number
- NCT05360966
- Sponsor
- Aerie Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-18
- Primary completion
- 2023-10-17
- Enrollment
- 467
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.